Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00786279 · ClinicalTrials.gov registry record · NA
Alcohol and Atherosclerosis Pilot Study
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT00786279 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 39 participants.
The verdict
NCT00786279, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
We propose a pilot study to determine the feasibility of a long-term clinical trial of alcohol intake on atherosclerosis, the first step in determining whether moderate drinking prevents cardiovascular disease and hence in understanding the full health effects of alcohol across the population. We will randomize 40 participants aged 55 and older to a six-month period of consumption of 1 glass per day of either pure alcohol (diluted to the strength of wine) or water. At baseline and after 6 months, we will measure several standard and novel cardiovascular risk markers in the blood and will perform magnetic resonance imaging to measure atherosclerosis of the aorta.
Interventions
- OTHER ethanol
- OTHER Ethanol-free beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2008-11 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00786279
The ClinicalTrials.gov registry entry for NCT00786279 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ethanol is the first listed.
NCT00786279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00786279 about?
NCT00786279 is a clinical study titled "Alcohol and Atherosclerosis Pilot Study". We propose a pilot study to determine the feasibility of a long-term clinical trial of alcohol intake on atherosclerosis, the first step in determining whether moderate drinking prevents cardiovascular disease and hence in understanding the full health effects of alcohol across the population. We wi...
What is the current status of trial NCT00786279?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2008-11. Estimated completion is 2015-04.
What interventions are being tested in trial NCT00786279?
The interventions under investigation include: ethanol (OTHER), Ethanol-free beverage (OTHER).
Who is sponsoring clinical trial NCT00786279?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.